Share of Cost, Interactions Between Two Molecules Thought To Play Critical Roles In Type II Diabetes And The Alzheimer’s Disease

Sunday, Aug. 25th 2013 8:00 AM

A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer’s disease. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa. A recent study suggests that people who suffer from type 2 diabetes face twice the risk of developing Alzheimer’s disease later in life compared to those who do not have diabetes.

Posted on Sunday, Aug. 25th 2013 8:00 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply

You must be logged in to post a comment.